Clinical Trial Update: Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing TransMID against standard treatment for Glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• TransMID

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED